SS 31 (Elamipretide)

Overview

Functional optimization of mitochondrial bioenergetics.

Mechanism of action

Evidence status: SS 31 and elamipretide are widely described as clinical stage and investigational, with peer reviewed mechanistic studies in biophysics and cellular models. A responsible product page should present it as a research tool peptide with an active clinical research history, not as a proven therapy unless approved in your jurisdiction for a specific indication.

For non experts: mitochondria are the cell’s “energy engines.” SS 31 is engineered to go where mitochondrial energy conversion happens and potentially support more efficient function under stress—this is a mechanism concept, not a guarantee of clinical benefit.

SS 31, also known as elamipretide, is a mitochondria targeted tetrapeptide designed to concentrate at the inner mitochondrial membrane and interact with cardiolipin, a key phospholipid that helps organize mitochondrial structure and electron transport chain function. Research suggests SS 31 can modify membrane interactions and mitochondrial stress responses, which is why it’s studied in conditions characterized by mitochondrial dysfunction, impaired bioenergetics, and oxidative stress signaling.

Authenticity

To validate your product, scan the QR code on the packaging or open the verification page for this product group.